(Q24187098)

inferred from title

author

Kurinchi Selvan Gurusamy

1

0 references

Stefan D. Anker

4

object named as

Stefan D Anker

0 references

author name string

Myura Nagendran

2

0 references

Jack F Broadhurst

3

0 references

Toby Richards

Cochrane Database of Systematic Reviews

5

0 references

publication date

31 December 2014

0 references

published in

0 references

cites work

Ferric carboxymaltose in patients with heart failure and iron deficiency

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

The effect of intravenous ferric carboxymaltose on red cell distribution width: a subanalysis of the FAIR-HF study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Rationale and design of the IRON-HF study: a randomized trial to assess the effects of iron supplementation in heart failure patients with anemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Pre-operative oral iron supplementation reduces blood transfusion in colorectal surgery - a prospective, randomised, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Efficacy and safety of oral lactoferrin supplementation in combination with rHuEPO-beta for the treatment of anemia in advanced cancer patients undergoing chemotherapy: open-label, randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Postoperative intravenous iron used alone or in combination with low-dose erythropoietin is not effective for correction of anemia after cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Rationale and design of Ferinject assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Safety and Efficacy of Intravenous Ferric Carboxymaltose (750 mg) in the Treatment of Iron Deficiency Anemia: Two Randomized, Controlled Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Ferric carboxymaltose with or without erythropoietin for the prevention of red-cell transfusions in the perioperative period of osteoporotic hip fractures: a randomized contolled trial. The PAHFRAC-01 project

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Effect of intravenous iron therapy on gastric acid secretion in iron-deficiency anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

The effect of intravenous and oral iron administration on perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

A randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Direct Comparison of the Safety and Efficacy of Ferric Carboxymaltose versus Iron Dextran in Patients with Iron Deficiency Anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Effect of iron therapy on platelet counts in patients with inflammatory bowel disease-associated anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Comparison of a combination ferrous fumarate product and a polysaccharide iron complex as oral treatments of iron deficiency anemia: a Taiwanese study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Treatment of iron-deficiency anemia in patients with subclinical hypothyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single-center randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Oral iron therapy for anaemia after orthopaedic surgery: randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Iron supplementation after femoral head replacement for patients with normal iron stores.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Effects of ferrous sulphate and non-ionic iron-polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Treatment of mild non-chemotherapy-induced iron deficiency anemia in cancer patients: comparison between oral ferrous bisglycinate chelate and ferrous sulfate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Erythrocytes: Better Tolerance of Iron Polymaltose Complex Compared with Ferrous Sulphate in the Treatment of Anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Safety and usefulness of intravenous iron sucrose in the management of preoperative anemia in patients with menorrhagia: a phase IV, open-label, prospective, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Comparison of ferrous sulfate and ferrous glycinate chelate for the treatment of iron deficiency anemia in gastrectomized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Role of oral versus IV iron supplementation in the erythropoietic response to rHuEPO: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Parenteral versus oral iron therapy for adults and children with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Comparison of rates of reported adverse events associated with i.v. iron products in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Anaemia in low-income and middle-income countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Iron replacement therapy in cancer-related anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Risk associated with preoperative anemia in noncardiac surgery: a single-center cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

The investigation and treatment of secondary anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Methods for combining randomized clinical trials: strengths and limitations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Treatment for women with postpartum iron deficiency anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Perioperative anemia: an independent risk factor for infection, mortality, and resource utilization in surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

The role of video capsule endoscopy in the evaluation of iron deficiency anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Assessment of risk of bias in randomized clinical trials in surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Does preoperative anemia adversely affect colon and rectal surgery outcomes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Iron deficiency anaemia: a review of diagnosis, investigation and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Industry sponsorship and research outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

A comparison of methods to detect publication bias in meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Intention-to-treat analysis: implications for quantitative and qualitative research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Treatments for iron-deficiency anaemia in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Ferrous versus ferric oral iron formulations for the treatment of iron deficiency: a clinical overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Anaemia is associated with reduced productivity of women workers even in less-physically-strenuous tasks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Parenteral iron therapy options

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Practical methods for incorporating summary time-to-event data into meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Anaemia is an independent predictor of death in patients hospitalized for acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Dietary iron intake and iron status of German female vegans: results of the German vegan study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Anemia of chronic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Iron Deficiency: Beyond Anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Iron supplementation for iron deficiency anemia in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Intravenous Iron Sucrose in Anemic and Non-anemic Iron Deficient Patients with CHF: A Randomized, Controlled, Observer-blinded Intervention Study (FERRIC-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

Darbepoetin alfa 300 or 500 μg once every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

7 January 2021

Intravenous or oral iron?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

7 January 2021

Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

7 January 2021

Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

7 January 2021

Iron deficiency and its management in patients undergoing lipoprotein apheresis. Comparison of two parenteral iron formulations

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

1 reference

7 January 2021

Ferric Carboxymaltose Prevents Recurrence of Anemia in Patients With Inflammatory Bowel Disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

7 January 2021

Post-operative anaemia in femoral neck fracture patients: does it need treatment? A single blinded prospective randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

7 January 2021

Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

7 January 2021

Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

7 January 2021

Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

7 January 2021

Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

7 January 2021

High-dose carbonyl iron for iron deficiency anemia: a randomized double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

7 January 2021

A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

7 January 2021

Effects of postoperative intravenous iron on transfusion requirements after lower limb arthroplasty

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

7 January 2021

Erythropoietin, iron, or both in heart failure: FAIR-HF in perspective

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

7 January 2021

Efficacy of intravenous iron sucrose administration for correcting preoperative anemia in patients scheduled for major orthopedic surgery

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

7 January 2021

Anemia and heart failure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

7 January 2021

The use of intravenous iron in patients with cancer related anaemia: don't overlook iron deficiency anaemia in colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

7 January 2021

Intravenous Iron Sucrose versus Oral Iron Supplementation for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease-A Randomized, Controlled, Open-Label, Multicenter Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

7 January 2021

Bioavailability of carbonyl iron: a randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

7 January 2021

The therapeutic effectiveness of various compounds containing iron

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

7 January 2021

A comparison of two iron tablet preparations in the treatment of iron deficiency anaemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

7 January 2021

Effect of correction of anemia in severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

7 January 2021

Randomized, multicenter, controlled trial comparing the efficacy and safety of darbepoetin alpha administered every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

7 January 2021

Increased importance of intravenous iron in chemotherapy-induced anemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

7 January 2021

Treatment of anaemia after joint replacement. A double-blind, randomised, controlled trial of ferrous sulphate versus placebo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

7 January 2021

The effect of iron supplementation on the level of haemoglobin after lower limb arthroplasty

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

7 January 2021

Iron supplementation for anemia after hip fracture surgery: a randomized trial of 300 patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010640.PUB2

7 January 2021